GameStop stock rises 15% pre-market as it pursues Bitcoin reserve plan
GameStop's Bitcoin strategy may stabilize its business amid digital challenges, aligning with a broader corporate shift towards crypto assets. The post GameStop stock rises 15% pre-market as it pursues Bitcoin reserve pl...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
GameStop's Bitcoin strategy may stabilize its business amid digital challenges, aligning with a broader corporate shift towards crypto assets.
The post GameStop stock rises 15% pre-market as it pursues Bitcoin reserve plan appeared first on Crypto Briefing.
Why this matters
This bitcoin story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on Crypto BriefingRelated market context
Strategy boosts Bitcoin holdings, stabilizes STRC near par value amid market challenges
Strategy's actions highlight the importance of financial agility and market confidence in navigating volatile crypto environments...
Lite Strategy Funds $5.4M Buyback With Litecoin Sales And Covered Calls
Lite Strategy has repurchased 4.9 million shares for $5.4 million, using Litecoin treasury activity and covered-call premiums to f...
Bitcoin (BTC) Price Today: Michael Saylor’s Strategy Reports $8.3B Loss as BTC Slides Below $64K
The BTC move comes shortly after Strategy reported an $8.33 billion operating loss for the second quarter of 2026, including an $8...
After $8.2B loss forced Bitcoin sales, Michael Saylor gives Strategy to September to repair broken dividend engine
Michael Saylor’s Strategy (formerly MicroStrategy) is targeting a September recovery for its STRC preferred stock as the company s...
Bitcoin Treasury Strategy Posts $8.2B Loss As BTC Price Suffered
Bitcoin Magazine Bitcoin Treasury Strategy Posts $8.2B Loss As BTC Price Suffered Bitcoin treasury company Strategy reported a los...
Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex, a Nasdaq-listed biotechnology company, is asking shareholders to authorize up to $800 million of financing tied to the RA...